Search Results 161-170 of 486 for 张家界下浮收u【TG:@xottc67788】安全匿名交易收U.AXS

1. Study of Adjuvant Regorafenib vs Placebo in Patients with Node Positive Esophageal Cancer who Completed Pre-operative Therapy - Mayo Clinic

   About this study. The purpose of this research study is to find out what effects, good and/or bad, the drug regorafenib has on stomach or esophagus cancer ...

2. Publications

   Publications. Gallego-Navarro C, Beckermann J, Linnaus ME, Swartz HJ, Stewart S, York JM, Gassner RR, Kasal CA, Seidel AG, Wachter CJ, Kooda KJ, Rich JR, ...

3. Retrospective Chart Review of Real-World Treatment Outcomes of Locally Advanced Unresectable Or Metastatic Urothelial Cancer Based on HER2 Expression - Mayo Clinic

   About this study. The purpose of this study is to estimate the real-world Objective Response Rate (rwORR) to standard therapy in subjects with locally ...

4. Thoracic aortic aneurysm - Doctors and departments - Mayo Clinic

   Learn about this serious condition in which the upper part of the body's main artery becomes weak and may rupture.

5. Head and neck cancers - Doctors and departments - Mayo Clinic

   Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

6. Alexander J. Ryu, M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic physician Alexander J. Ryu, M.D., researches artificial intelligence and machine-learning tools to help clinicians work more efficiently.

7. Evaluation of patients perceived health and fitness prior to surgery during the COIVD 19 pandemic - Mayo Clinic

   The primary aim of this study is to assess colon and rectal surgery patient perceptions of physical fitness, willingness to participate in a prehabilitation ...

8. A Study to Evaluate if Benralizumab Compared to Mepolizumab May be Beneficial in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) - Mayo Clinic

   All patients who complete the 52-week double-blind treatment period on IP may be eligible to continue into an open label extension (OLE) period. The OLE period ...

9. A Study of the Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity with Enteric LB1148 - Mayo Clinic

   Septic shock is a potentially life-threatening condition that can result in multi-organ dysfunction syndrome (MODS) and mortality. LB1148 was formulated to ...

10. A Study to Evaluate the Effectiveness and Safety of Vibegron Administered Orally for 12 Weeks to Women with Irritable Bowel Syndrome - Mayo Clinic

    The purpose of this study is to evaluate the effectiveness and safety of vibegron, a beta-3 adrenergic receptor (β3-AR) agonist, in the treatment of pain ...